What is PHAR's market capitalization?

Egyptian International Pharmaceutical Industries Co. has a market capitalization of about EGP 16.77B.

Does PHAR pay dividends?

Yes — Egyptian International Pharmaceutical Industries Co. paid EGP 3.5 per share for fiscal 2025, a dividend yield of 3.52% at the last price.

What is PHAR's P/E ratio?

Egyptian International Pharmaceutical Industries Co. trades at a trailing price-to-earnings ratio of 11.17.

Where can I track PHAR?

This Starta Markets page shows Egyptian International Pharmaceutical Industries Co.'s EGX quote (delayed 15 minutes), key statistics, financial statements, dividends, technicals and news, in Arabic and English.

Egyptian International Pharmaceutical Industries Co. (PHAR) Share Price — EGX

EGP 99.4+2.06%Indicator average: −0.29 (−1 to +1)

Egyptian International Pharmaceutical Industries Co. (PHAR) trades on the Egyptian Exchange (EGX) in the Health Care & Pharmaceuticals sector. Last updated 28 Oct 2026, 13:20 (Cairo time).

What is Egyptian International Pharmaceutical Industries Co.’s share price today? PHAR last traded at EGP 99.4 (+2.06% on the day), for a market value of EGP 16.77 billion and a dividend yield of 3.52%. Its 52-week range is EGP 67.5 to 178.99.

PHAR price performance

1W: -5.8%
1M: -7.8%
3M: +0.9%
6M: +14.2%
YTD: +25.7%
1Y: +22.7%
5Y: +197.7%

Price change from EGX closing prices, adjusted for recorded splits and bonus issues; cash dividends are not included. A period that spans an unexplained price jump is not shown. Past performance does not indicate future results.

About Egyptian International Pharmaceutical Industries Co.

Egyptian International Pharmaceutical Industries Co. engages in the manufacture and distribution of medicines and other medical products. Its products include anesthetics, analgesics, antibiotics, antacids, decongestants, diuretics, laxatives, blood substitutes, vitamins, and minerals. The company was founded on December 3, 1980, and is headquartered in Tenth of Ramadan City, Egypt.

Industry:: Pharmaceuticals: Other
CEO:: Ahmed Said Mohammed Kilany El-Bucheiry
ISIN:: EGS38081C013
Website:: www.eipico.com.eg

PHAR key statistics

Last price: EGP 99.4
Previous close: EGP 93.1
Day change: 2.06%
52-week range: EGP 67.5 – 178.99
Volume: 629,348
Shares outstanding: 168.76M
Free float: 31.64%
Market cap: EGP 16.77B
P/E (trailing): 11.17
P/B: 2.63
Dividend yield (FY 2025): 3.52%
Revenue (TTM): EGP 9.44B
Net income (TTM): EGP 1.44B
ROE: 26.46%
Book value / share: EGP 37
Beta (1Y): 0.63
50-day MA: EGP 117.4
200-day MA: EGP 95.32
RSI (14): 35.3

Data as of 28 Oct 2026, 13:20 (Cairo time). EGX market data; financial statements from company disclosures. Prices are delayed 15 minutes during EGX trading hours (Sun–Thu).

Compare with other Health Care & Pharmaceuticals stocks

Latest Egyptian International Pharmaceutical Industries Co. news

EIPICO stock holds bullish trend amid rising volumes21 Apr 2026
EIPICO to disburse over EGP 590.5m dividends for 202530 Mar 2026
EIPICO stock is poised to break out of historical peak – Analysis5 Feb 2026

Key terms behind the PHAR figures

Market Capitalization: Market capitalization is the total market value of a company’s outstanding shares, calculated as the share price multiplied by the number of issued shares. It is the standard measure used to rank the size of listed companies and to weight them in indices such as the EGX 30. Market cap changes continuously as the share price moves.
Price-to-Earnings (P/E) Ratio: The price-to-earnings ratio divides a company’s share price by its earnings per share, showing how many pounds investors pay for each pound of annual profit. It is one of the most widely used valuation multiples for comparing listed companies within the same sector. A trailing P/E uses reported earnings, while a forward P/E uses forecast earnings.
Price-to-Book (P/B) Ratio: The price-to-book ratio compares a company’s share price with its book value per share, which is shareholders’ equity divided by the number of shares. A ratio of 1 means the stock trades at exactly its accounting net worth. The multiple is used widely for valuing banks and other asset-heavy businesses on the EGX.
Dividend Yield: Dividend yield is the annual cash dividend per share expressed as a percentage of the current share price. It measures the income a shareholder receives from distributions relative to the market price of the stock. Because the calculation uses the market price, the yield rises when the price falls and falls when the price rises, assuming the dividend is unchanged.

Frequently asked questions

What is Egyptian International Pharmaceutical Industries Co. (PHAR) share price today?: Egyptian International Pharmaceutical Industries Co. last traded at EGP 99.4 on the Egyptian Exchange (as of 28 Oct 2026, 13:20, Cairo time). Prices update every 15 minutes during EGX trading hours.
What is PHAR's market capitalization?: Egyptian International Pharmaceutical Industries Co. has a market capitalization of about EGP 16.77B.
Does PHAR pay dividends?: Yes — Egyptian International Pharmaceutical Industries Co. paid EGP 3.5 per share for fiscal 2025, a dividend yield of 3.52% at the last price.
What is PHAR's P/E ratio?: Egyptian International Pharmaceutical Industries Co. trades at a trailing price-to-earnings ratio of 11.17.
What sector is Egyptian International Pharmaceutical Industries Co. in?: Egyptian International Pharmaceutical Industries Co. is listed on the Egyptian Exchange (EGX) in the Health Care & Pharmaceuticals sector.
Where can I track PHAR?: This Starta Markets page shows Egyptian International Pharmaceutical Industries Co.'s EGX quote (delayed 15 minutes), key statistics, financial statements, dividends, technicals and news, in Arabic and English.